This is a routine periodic disclosure of an ongoing buyback program with no new information. Traders should monitor future filings for any changes to the program or material corporate developments.
Price Chart
Executive Summary
Novo Nordisk filed a routine weekly update on its ongoing DKK 15 billion share repurchase program, reporting B share repurchases from August 4-7, 2026 totaling 820,000 shares for approximately DKK 246.8 million. Cumulative repurchases under the program since February 4, 2026 reached 27,884,179 B shares at an average price of DKK 279.01, for a total transaction value of DKK 7.78 billion. This is a standard periodic disclosure with no new financial results or guidance.
Key Facts
- Weekly repurchases Aug 4-7, 2026: 820,000 B shares for ~DKK 246.8 million
- Cumulative under program since May 6, 2026: 13,125,000 B shares for DKK 3.98 billion
- Overall program since Feb 4, 2026: 27,884,179 B shares at avg DKK 279.01 for DKK 7.78 billion
- Treasury shares: 41,924,876 B shares (0.9% of share capital)
- Program authorized up to DKK 15 billion over 12 months ending Feb 1, 2027
Financial Impact
Routine buyback update; no new financial impact beyond previously announced program
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (NVO), Batch item 1 | 0001171843-26-005376 |
| Document: 0001171843-26-005376-index-headers.html | 0001171843-26-005376 |
| Document: 0001171843-26-005376-index.html | 0001171843-26-005376 |
| Document: 0001171843-26-005376.txt | 0001171843-26-005376 |
| 6-K Filing (NVO), Batch item 5 | 0001171843-26-005376 |
| Document: 0001171843-26-005376-index-headers.html | 0001171843-26-005376 |
| Document: 0001171843-26-005376-index.html | 0001171843-26-005376 |
| Document: 0001171843-26-005376.txt | 0001171843-26-005376 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 6d ago | 6-K | $39.13 | awaiting T+20 | awaiting T+20 | $40.00 (+2.22%) |
Oct 26, 2026 7d ago | Court Ruling | $38.67 | awaiting T+20 | awaiting T+20 | $40.00 (+3.44%) |
Oct 19, 2026 13d ago | 6-K | $38.42 | awaiting T+20 | awaiting T+20 | $40.00 (+4.11%) |
Oct 13, 2026 19d ago | 6-K | $38.06 | awaiting T+20 | awaiting T+20 | $40.00 (+5.10%) |
Oct 6, 2026 26d ago | 6-K | $37.53 | awaiting T+20 | awaiting T+20 | $40.00 (+6.58%) |
Sep 28, 2026 4w ago | 6-K | $38.71 $38.95 | ▲ +0.61% | ▲ +0.64% | $40.00 (+3.33%) |
Sep 23, 2026 5w ago | Court Ruling | $38.62 $39.43 | ▲ +2.10% | ▲ +2.52% | $40.00 (+3.57%) |
Sep 21, 2026 5w ago | 6-K | $39.80 $38.42 | ▼ −3.47% | ▼ −2.56% | $40.00 (+0.50%) |
Sep 17, 2026 6w ago | 6-K | $43.19 $39.22 | ▼ −9.19% | ▼ −10.40% | $40.00 (−7.39%) |
Sep 15, 2026 6w ago | 6-K | $42.53 $38.06 | ▼ −10.51% | ▼ −13.23% | $40.00 (−5.95%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers